Intratumoral INF-γ triggers an antiviral state in GL261 tumor cells: a major hurdle to overcome for oncolytic vaccinia virus therapy of cancer
Oncolytic vaccinia virus (VACV) therapy is an alternative treatment option for glioblastoma multiforme. Here, we used a comparison of different tumor locations and different immunologic and genetic backgrounds to determine the replication efficacy and oncolytic potential of the VACV LIVP 1.1.1, an a...
Main Authors: | Christina Kober, Stephanie Weibel, Susanne Rohn, Lorenz Kirscher, Aladar A Szalay |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770516300110 |
Similar Items
-
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
by: Kober, Christina
Published: (2015) -
Oncolytic vaccinia therapy of squamous cell carcinoma
by: Yu Yong A, et al.
Published: (2009-07-01) -
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
by: Dobrin D. Draganov, et al.
Published: (2019-03-01) -
Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice
by: Yu Yong A, et al.
Published: (2011-09-01) -
Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
by: Dobrin D. Draganov, et al.
Published: (2021-10-01)